Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Change in Account Payables: 2017-2019

Historic Change in Account Payables for Astria Therapeutics (ATXS) over the last 3 years, with Dec 2019 value amounting to -$893,000.

  • Astria Therapeutics' Change in Account Payables fell 330.15% to -$893,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$211,000, marking a year-over-year decrease of 131.87%. This contributed to the annual value of $2.8 million for FY2024, which is 287.17% up from last year.
  • According to the latest figures from Q4 2019, Astria Therapeutics' Change in Account Payables is -$893,000, which was down 206.06% from $842,000 recorded in Q3 2019.
  • Astria Therapeutics' 5-year Change in Account Payables high stood at $1.1 million for Q2 2017, and its period low was -$893,000 during Q4 2019.
  • Moreover, its 3-year median value for Change in Account Payables was -$80,000 (2019), whereas its average is -$15,083.
  • Per our database at Business Quant, Astria Therapeutics' Change in Account Payables skyrocketed by 190.44% in 2018 and then slumped by 330.15% in 2019.
  • Quarterly analysis of 3 years shows Astria Therapeutics' Change in Account Payables stood at -$429,000 in 2017, then soared by 190.44% to $388,000 in 2018, then plummeted by 330.15% to -$893,000 in 2019.
  • Its Change in Account Payables was -$893,000 in Q4 2019, compared to $842,000 in Q3 2019 and -$208,000 in Q2 2019.